Abstract:The diterpenoid paclitaxel (Taxol ® ) is a blockbuster anticancer agent that was originally isolated from the Pacific yew ( Taxus brevifolia ) five decades ago. Despite the wealth of information gained over the years on Taxol research, there still remains supply issues to meet increasing clinical demand. Although alternative Taxol production methods have been developed, they still face several drawbacks that cause supply shortages and high production costs. It is highly desired to develop biotechnological production platforms for Taxol, however, there are still gaps in our understanding of the biosynthetic pathway, catalytic enzymes, regulatory and control mechanisms that hamper production of this critical drug by synthetic biology approaches. Over the past 5 years, significant advances were made in metabolic engineering and optimization of the Taxol pathway in different hosts, leading to accumulation of taxane intermediates. Computational and experimental approaches were leveraged to gain mechanistic insights into the catalytic cycle of pathway enzymes and guide rational protein engineering efforts to improve catalytic fitness and substrate/product specificity, especially of the cytochrome P450s (CYP450s). Notable breakthroughs were also realized in engineering the pathway in plant hosts that are more promising in addressing the challenging CYP450 chemistry. Here, we review these recent advances and in addition, we summarize recent transcriptomic data sets of Taxus species and elicited culture cells, and give a bird’s-eye view of the information that can be gleaned from these publicly available resources. Recent mining of transcriptome data sets led to discovery of two putative pathway enzymes, provided many lead candidates for the missing steps and provided new insights on the regulatory mechanisms governing Taxol biosynthesis. All these inferences are relevant to future biotechnological production of Taxol.

Research Progress of Paclitaxel Drug Source Solution and Extraction and Separation Technology

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Biosynthesis of paclitaxel using synthetic biology

[Advances in paclitaxel biosynthesis and transcriptional regulation mechanisms]

Medicinal Chemistry of Paclitaxel and Its Analogues

Recent Advances in Metabolic Engineering, Protein Engineering, and Transcriptome-Guided Insights Toward Synthetic Production of Taxol

Paclitaxel: A Landmark Natural Anticancer Drug

Advances On Paclitaxel Biosynthesis In Taxus

Biosynthesis and Regulation of Paclitaxel in Taxus

Current and Emerging Options for Taxol Production.

Mining natural products related to paclitaxel reveals the possible biosynthetic pathway of paclitaxel

Post-genomic illumination of paclitaxel biosynthesis

Taxol Origins and Production Development 2 . 1 Natural Role and Therapeutic Utilization

Progress in research on paclitaxel and tumor immunotherapy

Strategies Of Improving Paclitaxel Biosynthesis In Taxus

Highly Efficient and Simultaneous Production of Thirteen Taxanes from Taxus × Media and Mining of Their New Bioactivity

Strategies in Taxol development. A review.

Recent advances in paclitaxel biosynthesis and regulation

Taxol: biosynthesis, molecular genetics, and biotechnological applications

Research Progress on Taxus Extraction and Formulation Preparation Technologies

Improved Production of Paclitaxel from Suspension Culture of Taxus Chinensis Var. Mairei by in Situ Extraction with Organic Solvents